clavinova We know the US requirements for a trade deal,
because they have published them and because the US has been quite open before about its demands
Do you agree with these terms ?
If sovereignty is important to you, then a US trade deal would take away far more than the EU required
https://www.newstatesman.com/politics/uk/2019/06/uk-has-much-fear-us-trade-agreement
American Ambassador Woody Johnson’s comment to <a class="break-all" href="http://go.mumsnet.com/?xs=1&id=470X1554755&url=www.theguardian.com/politics/2019/jun/02/us-wants-access-to-nhs-in-post-brexit-deal-ambassador-to-uk-says" target="_blank">Andrew Marrr*r on Sunday that healthcare would need to be on the table in any future trade talks
only served to make agreeing a fully-fledged deal all the more difficult.
That the US will drive a hard bargain in any future negotiation with the UK should come as no surprise.
Only the EU, and perhaps China, have the economic heft to negotiate on near-level terms with the Americans,
< hence why Trump & US oligarchs want to seperate the individual countries of the EU
.....
The US’s objectives for its negotiation with the UK were published in <a class="break-all" href="http://go.mumsnet.com/?xs=1&id=470X1554755&url=ustr.gov/sites/default/files/Summary_of_U.S.-UK_Negotiating_Objectives.pdf" target="_blank">February
....
For example:
alongside normal talk of tariff and quota removal,
the UK must jettison food hygiene rules that currently restrict US exports of beef, pork, chicken and dairy;
rules stipulating which products qualify for tariff-free treatment under the agreements must specifically incentivise production on US territory;
and the agreement should include a mechanism allowing for the US to take appropriate action if the UK negotiates an agreement with a “non-market economy” (see: China).
....
US demands regarding reimbursement regimes for pharmaceuticals and medical devices give greater cause for thought.
The US has long taken issuee* with the fact that the NHS’s approach to drug procurement
- where it makes its own assessment as to the fair value of the drugs it buys -
pulls down prices worldwide.
.....
due to the NHS’s global significance and market power, the incentives for the US to push the UK harder are more pronounced.